Chromophobe
Showing 1 - 25 of 28
Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)
Recruiting
- Kidney Cancer
- +11 more
- 13C-Glucose
- +4 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma
Recruiting
- Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
- +6 more
-
Basking Ridge, New Jersey
- +6 more
Feb 2, 2022
Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia
Recruiting
- Renal Cell Carcinoma
- +5 more
-
Albury, New South Wales, Australia
- +10 more
Feb 14, 2022
Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia
Active, not recruiting
- Renal Cell Carcinoma
- +5 more
-
Albury, New South Wales, Australia
- +18 more
Feb 14, 2022
Biomarkers of Renal Cancer
Recruiting
- Renal Cell Carcinoma
- +3 more
-
Firenze, Italy
- +3 more
Mar 14, 2023
Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,
Recruiting
- Advanced Renal Cell Carcinoma
- +8 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 24, 2023
Renal Cancer, Birt-Hogg-Dube Syndrome Trial run by the NCI (Everolimus)
Terminated
- Renal Cancer
- Birt-Hogg-Dube Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 7, 2019
Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)
Recruiting
- Non-clear Renal Cell Carcinoma
-
Nanjing, Jiangsu, China
- +1 more
Mar 13, 2023
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Von Hippel-Lindau: Clinical Manifestations, Diagnosis,
Recruiting
- Kidney Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for
Not yet recruiting
- Kidney Tumor
- +2 more
- (no location specified)
Feb 6, 2023
Brain and CNS Tumors Trial (drug, genetic, other)
Withdrawn
- Brain and Central Nervous System Tumors
- temozolomide
- +5 more
- (no location specified)
Jul 29, 2020
Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)
Terminated
- Kidney Cancer
-
Boston, Massachusetts
- +3 more
Apr 26, 2021
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States
Recruiting
- Bladder Adenocarcinoma
- +45 more
- Cabozantinib S-malate
- +2 more
-
Birmingham, Alabama
- +563 more
Aug 24, 2022
Renal Cell Carcinoma Trial (Immunohistochemistry)
Unknown status
- Renal Cell Carcinoma
- Immunohistochemistry
- (no location specified)
Sep 29, 2018
Perfusion Scanning's for Kidney Tumors
Completed
- Kidney Cancer
-
Roskilde, DenmarkRoskilde Hospital
Jan 22, 2018
Advanced Non-clear Cell Renal Cell Carcinoma Trial in Canada, United Kingdom, United States (Everolimus, Sunitinib)
Completed
- Advanced Non-clear Cell Renal Cell Carcinoma
-
Chicago, Illinois
- +17 more
Dec 15, 2017
Diabetes Trial in Worldwide (Albiglutide 30 mg, Albiglutide 50 mg, Albiglutide matching )
Completed
- Diabetes Mellitus
- Albiglutide 30 mg
- +2 more
-
Birmingham, Alabama
- +607 more
Feb 11, 2019
Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma Trial in Seoul (pazopanib)
Completed
- Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
-
Seoul, Korea, Republic ofSamsung medical Center
Apr 24, 2017
Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,
Completed
- Chromophobe Renal Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Boston, Massachusetts
- +4 more
Jan 6, 2015
Renal Cell Cancer, Kidney Cancer Trial in Houston (Sunitinib Malate)
Completed
- Renal Cell Cancer
- Kidney Cancer
- Sunitinib Malate
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 4, 2016
Kidney Tumors Trial in France (surgery or biopsy of the kidney tumor)
Terminated
- Kidney Neoplasms
- surgery or biopsy of the kidney tumor
-
Grenoble, France
- +6 more
Jun 3, 2015
Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood CNS Choriocarcinoma, Childhood CNS Germinoma Trial in Canada, United
Terminated
- Childhood Atypical Teratoid/Rhabdoid Tumor
- +45 more
- gamma-secretase/Notch signalling pathway inhibitor RO4929097
- +3 more
-
Palo Alto, California
- +11 more
Nov 4, 2014